Target intelligence / Profile preview

Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (DDOST) (OST48)

Target
OST48
Molecular classification
Enzyme subunit, Oligosaccharyltransferase complex, Receptor
01

Overview

Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (DDOST), also known as OST48, is a critical non-catalytic subunit of the oligosaccharyltransferase (OST) complex located in the endoplasmic reticulum membrane (UniProt: P39656). Its primary biological function is to facilitate the transfer of a high-mannose oligosaccharide from a dolichol-linked donor to specific asparagine residues on nascent polypeptides, a process known as N-linked glycosylation (PubMed: 25524443). This modification is essential for proper protein folding, stability, and intracellular trafficking. Beyond its role in glycosylation, OST48 (as AGER1) is involved in the clearance of advanced glycation end-products (AGEs), which are linked to inflammatory and oxidative stress pathways in diabetes and kidney disease (PubMed: 21832108). Mutations in the DDOST gene lead to congenital disorder of glycosylation type Ih (DDOST-CDG), characterized by multi-systemic clinical features including developmental delay and hypotonia (OMIM: 602202). While not a common target for current clinical therapeutics, the OST complex is a subject of research for its potential in treating certain cancers and viral infections where glycosylation is a key factor in pathogenesis, with small molecules like NGI-1 serving as experimental inhibitors (PubMed: 28234446).

Other names
DDOSTOligosaccharyltransferase 48 kDa subunitAGER1Advanced glycation end-product receptor 1WBP1 homologOST48
02

Mechanism of action

Inhibition of the oligosaccharyltransferase (OST) complex, thereby preventing the N-linked glycosylation of nascent proteins in the endoplasmic reticulum (PubMed: 28234446).

03

Biological functions

N-linked glycosylationProtein foldingAdvanced glycation end-product metabolismEndoplasmic reticulum-associated degradation
04

Disease associations

Congenital disorder of glycosylation type IhDiabetes mellitusChronic kidney diseaseCancerViral infection
05

Safety considerations

Potential for systemic toxicity due to essential role in protein maturationDevelopmental defectsImmune system dysfunctionLiver toxicity
06

Interacting drugs

NGI-1
07

Biomarkers

Hypoglycosylated serum transferrinAdvanced glycation end-products (AGEs) levels

Beyond the preview

Go deeper on Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (DDOST) (OST48).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (DDOST) (OST48).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call